NCT06535620

Brief Summary

Introduction: Cardiovascular diseases (CVDs) are the leading cause of global mortality, despite being preventable. Moderate wine consumption has been associated with one of the preventative approaches due to its benefits on cardiovascular health, including endothelial protection and antioxidant effects, attributed to its chemical composition, such as flavonoids. Objective: To assess endothelial function through flow-mediated dilation after the consumption of red wine compared to non-alcoholic wine. Methodology: A parallel, randomized, placebo-controlled clinical trial with a blinded evaluator will be conducted with 20 healthy participants, evaluated at two distinct time points. Participants will be selected to receive either red wine or non-alcoholic wine and will be crossed over after 7 days to receive the opposite beverage from the initial one. The primary outcome will be the change in flow-mediated dilation of the brachial artery pre- and post-intervention in both groups. The secondary outcomes will include the flow-mediated dilation values, brachial artery diameter after the intervention, and measurements of systolic blood pressure (SBP) and diastolic blood pressure (DBP).

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for phase_1 healthy

Timeline
Completed

Started Aug 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 28, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 2, 2024

Completed
11 days until next milestone

Study Start

First participant enrolled

August 13, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2024

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2024

Completed
Last Updated

August 16, 2024

Status Verified

August 1, 2024

Enrollment Period

3 months

First QC Date

July 28, 2024

Last Update Submit

August 13, 2024

Conditions

Keywords

winecardiovascular disease

Outcome Measures

Primary Outcomes (1)

  • Flow-mediated dilation

    Evaluate flow-mediated dilation after the consumption of red wine compared to placebo

    40 minutes after the substance intake

Secondary Outcomes (4)

  • Heart rate

    40 minutes after the substance intake

  • Blood pressure

    40 minutes after the substance intake

  • Brachial artery diameter at rest

    40 minutes after the substance intake

  • Brachial artery diameter after endothelial stress

    40 minutes after the substance intake

Study Arms (2)

red wine with alcohol

EXPERIMENTAL

The red wine group

Other: red wine with alcohol

red wine without alcohol

PLACEBO COMPARATOR

The non-alcoholic wine group

Other: red wine without alcohol

Interventions

200 ml of red wine - Demi sec Bordeaux wine 'La Dorni' (alcohol content at 20ºC of 10.1% - Alves \& Martins Bebidas Especiais LTDA - Bandeirantes, Parana - Brazil)

red wine with alcohol

200 ml of red wine without alcohol - Demi sec Bordeaux wine 'Casa Navaronne' (alcohol content at 20ºC of 0.23% - Alves \& Martins Bebidas Especiais LTDA - Bandeirantes, Parana - Brazil)

red wine without alcohol

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • consume alcohol sporadically

You may not qualify if:

  • continuous medication, including anti-inflammatories
  • pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Cardiovascular Diseases

Interventions

Ethanol

Intervention Hierarchy (Ancestors)

AlcoholsOrganic Chemicals

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Cardiology

Study Record Dates

First Submitted

July 28, 2024

First Posted

August 2, 2024

Study Start

August 13, 2024

Primary Completion

October 30, 2024

Study Completion

November 15, 2024

Last Updated

August 16, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share